Akari Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKTX and other ETFs, options, and stocks.

About AKTX

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. 

CEO
Abizer Gaslightwala
CEOAbizer Gaslightwala
Employees
6
Employees6
Headquarters
Tampa, Florida
HeadquartersTampa, Florida
Founded
2004
Founded2004
Employees
6
Employees6

AKTX Key Statistics

Market cap
208.23M
Market cap208.23M
Price-Earnings ratio
-0.02
Price-Earnings ratio-0.02
Dividend yield
Dividend yield
Average volume
16.07K
Average volume16.07K
High today
$4.91
High today$4.91
Low today
$4.16
Low today$4.16
Open price
$4.80
Open price$4.80
Volume
6.16K
Volume6.16K
52 Week high
$63.20
52 Week high$63.20
52 Week low
$4.16
52 Week low$4.16

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.